---
title: "Webinar: Developing novel human iPSC models for atrial fibrillation"
description: In this webinar, learn how to leverage human iPSC technology for in vitro modeling of atrial fibrillation.
---

[Webinars ](https://www.ncardia.com/insights/webinars)

# [Webinar: Developing novel human iPSC models for atrial fibrillation](https://www.ncardia.com/insights/webinars/webinar-developing-novel-human-ipsc-models-for-atrial-fibrillation)

 Written by [Thomas Hutschalik, PhD candidate](https://www.ncardia.com/insights/webinars/author/thomas-hutschalik-phd-candidate) | April 22, 2022

Atrial Fibrillation (AF) is the most prevalent cardiac arrhythmia. It is a progressive, multifactorial disease, initiating with electrophysiological abnormalities and developing into morphological, structural and substrate pathologies. As the disease mechanisms are not yet fully understood, a lack of effective and lasting treatments continues.  
Human-induced pluripotent stem cell (iPSC)-derivatives are a unique tool to improve *in vitro *investigation of AF disease mechanisms and can help elucidate new treatments. At Ncardia, we recently developed a human iPSC-based AF model to investigate the influence of inflammation and immune cells on atrial arrhythmias.  
In this webinar, we will present a new coculture approach, combining human [iPSC-derived atrial cardiomyocytes](https://www.ncardia.com/discovery-services/modeling/atrial-cardiomyocytes) and macrophages to study new underlying mechanisms of AF and the effect of inflammation targeting compounds in the development of atrial arrhythmias through [phenotype-rescue screening](https://www.ncardia.com/discovery-services/screening).

### In this webinar you will:

- Learn how human iPSC technology can be utilized for *in vitro* modeling of atrial fibrillation
- Gain insights into possible novel mechanisms underlying the onset of atrial fibrillation
- Discover new drug treatment possibilities for inflammation related arrhythmia treatment

[View full post](https://www.ncardia.com/insights/webinars/webinar-developing-novel-human-ipsc-models-for-atrial-fibrillation)

```json
{
  "@context" : "http://schema.org",
  "@type" : "BlogPosting",
  "author" : {
    "@type" : "Person",
    "name" : "Thomas Hutschalik, PhD candidate"
  },
  "dateModified" : "2022-08-29T08:48:07.456Z",
  "datePublished" : "2022-04-22T04:00:00Z",
  "headline" : "Webinar: Developing novel human iPSC models for atrial fibrillation",
  "image" : {
    "@type" : "ImageObject",
    "height" : 1080,
    "url" : "https://25505018.fs1.hubspotusercontent-eu1.net/hubfs/25505018/Blog%20Featured%20Images/Featured%20image_webinar%202%20atrial%20fibrillation.png",
    "width" : 1920
  },
  "mainEntityOfPage" : "https://www.ncardia.com/insights/webinars/webinar-developing-novel-human-ipsc-models-for-atrial-fibrillation",
  "publisher" : {
    "@type" : "Organization",
    "logo" : {
      "@type" : "ImageObject",
      "height" : 60,
      "url" : "/hs/hsstatic/content_shared_assets/static-1.4092/img/default-amp-logo.png",
      "width" : 60
    },
    "name" : "Webinars"
  }
}
```